NYSE Euronext accueille Chemtura Corporation, déjà cotée sur le NYSE, sur son marché européen


Chemtura Corporation (ticker symbol: CHMT), a U.S. global specialty chemicals company, announced its Fast Path cross-listing on NYSE Euronext in Paris today. Chemtura Corporation is the first NYSE-listed company in 2012 to take advantage of this streamlined and cost-effective process and the fourteenth to do so since the facility was made available by NYSE Euronext in 2008.
The Fast Path listing enables US-listed, non-EU companies to use their existing filings with the Securities and Exchange Commission (SEC) for a listing on NYSE Euronext’s European market. This listing process can be used in connection with various transactions, including initial public offerings, follow-on capital raisings, spin-offs and direct listings without capital raising.

Chemtura Corporation develops, manufactures and markets innovative application-focused specialty chemical solutions and consumer products. The company holds a leading position in diversified industries, including automotive, electronics, pool and spa chemicals, agriculture and transportation. With approximately 4,500 employees worldwide, Chemtura Corporation manufactures products at 31 sites and sells products in over 100 countries. The Europe, Middle East and Africa region represented 30% of Chemtura’s 2011 sales.

A Fast Path listing is yet another example of how NYSE Euronext enables companies to connect to other markets more effectively. We are delighted to welcome Chemtura Corporation to the community of NYSE Euronext listed companies”, said Diederik Zandstra, Head of International Listings at NYSE Euronext. “This operation will enable the company to gain access to the dynamic and vibrant European market, and increase its visibility enabling it to expand its operations and reinforce its global identity ”.

Craig A. Rogerson, Chairman, President and CEO of Chemtura Corporation, commented: “We are pleased to be cross-listing on NYSE Euronext in Paris.  There are many exciting investment opportunities for us in Europe.  All are important steps in building recognition as a truly global enterprise”.

Chemtura Corporation’s Common Stock was admitted to listing and trading on NYSE Euronext by direct listing of the existing 100,145,032 shares of which 98,665,045 are outstanding, making up the company's issued capital stock as of March 31, 2012.

The admission price of the company’s shares was set at €12.18 each. Chemtura Corporation’s market capitalization on the day of admission amounted to €1.22 billion.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2023, Euronext N.V. - All rights reserved.